Compare VRRM & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRRM | LMAT |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2016 | 2006 |
| Metric | VRRM | LMAT |
|---|---|---|
| Price | $4.67 | $91.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $25.90 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 10.7M | 246.0K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 347.37 | 30.57 |
| EPS | 0.17 | ★ 0.68 |
| Revenue | $132,969,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $6.84 | $14.21 |
| Revenue Next Year | $6.88 | $8.88 |
| P/E Ratio | ★ $26.47 | $135.79 |
| Revenue Growth | ★ 14.61 | 13.53 |
| 52 Week Low | $3.40 | $79.01 |
| 52 Week High | $25.83 | $118.01 |
| Indicator | VRRM | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 23.47 | 35.10 |
| Support Level | $3.40 | $89.81 |
| Resistance Level | $25.10 | $92.25 |
| Average True Range (ATR) | 0.53 | 2.86 |
| MACD | 0.02 | 0.21 |
| Stochastic Oscillator | 12.71 | 16.39 |
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe, and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three reportable segments: Commercial Services, Government Solutions, and Parking Solutions. Maximum revenue is generated from the Commercial Services segment, which offers toll and violation management solutions and title and registration services for commercial fleet customers, including RACs and FMCs in North America. In Europe, it provides tolling and violations processing services.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.